Skip to main content
An official website of the United States government

monoclonal antibody RAV12

A chimeric monoclonal antibody directed against a primate-restricted N-linked carbohydrate epitope (glycotope) expressed on various human carcinomas with potential antineoplastic activity. Following binding, monoclonal antibody RAV12 disrupts sodium channels of tumor cells expressing this glycotope, resulting in cell and organelle swelling, loss of membrane integrity, and cell death.
Synonym:anti-RAAG12 monoclonal antibody
RAV12
Abbreviation:anti-RAAG12 MOAB
Search NCI's Drug Dictionary